Pulmonary artery sealing with ultrasonic energy in open lobectomy: A phase I clinical trial

被引:14
|
作者
Goudie, Eric [1 ]
Thiffault, Vicky [1 ]
Jouquan, Adeline [1 ]
Lafontaine, Edwin [1 ]
Ferraro, Pasquale [1 ]
Liberman, Moishe [1 ]
机构
[1] Univ Montreal, Endoscop Tracheobronchial & Oesophageal Ctr, Endoscop Tracheobronchial & Oesophageal Ctr CETOC, CHU Montreal,Dept Surg,Div Thorac Surg, Montreal, PQ, Canada
来源
关键词
pulmonary artery sealing; energy; VATS lobectomy; ultrasonic energy; THORACOSCOPIC LOBECTOMY; LUNG-CANCER; SURGERY LOBECTOMY; VASCULAR LIGATION; THORACIC-SURGERY; STAGE-I; RESECTION; DEVICES; COMPLICATIONS; THORACOTOMY;
D O I
10.1016/j.jtcvs.2016.12.049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Pulmonary artery branch sealing in video-assisted thoracoscopic surgical lobectomy is usually achieved with vascular endostaplers. Iatrogenic pulmonary artery injury may be caused by endostaplers. We evaluated the safety of pulmonary artery sealing with an ultrasonic energy vessel-sealing device in a phase I clinical trial evaluating in vivo safety of the device during open lobectomy. Methods: Patients scheduled to undergo elective open (thoracotomy) pulmonary lobectomy were prospectively enrolled. Target sample size was 10 patients. Pulmonary artery diameter was measured intraoperatively. All branches <= 7mmwere divided with an ultrasonic energy vessel-sealing device. The remainder of the lobectomy was performed in a standard fashion. Intraoperative and postoperative bleeding were strictly recorded. Results: Eighteen patients were prospectively enrolled. Eight patients were not amenable to pulmonary artery sealing with the device. In the 10 patients included in the analysis, a total of 14 pulmonary arteries were sealed with the ultrasonic device. The mean vessel diameter was 5 mm (range, 2-7 mm). One patient underwent reoperation for bronchial artery bleeding (vessel not sealed with device). There was no intra-or postoperative bleeding related to ultrasonic pulmonary artery sealing. There was no postoperative mortality. Conclusions: Pulmonary artery sealing for vessels with diameter <= 7 mm was safely achieved with an ultrasonic energy vessel-sealing device in open lobectomy. The use of ultrasonic energy vessel-sealing devices in video-assisted thoracoscopic surgical lobectomy may have the advantage of making small, short, pulmonary artery branch sealing safer than with vascular endostaplers. Further studies are necessary before widespread application in lobectomy, including video-assisted thoracoscopic surgical lobectomy.
引用
收藏
页码:1600 / 1606
页数:7
相关论文
共 50 条
  • [41] Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria
    D'Avola, Delia
    Lopez-Franco, Esperanza
    Sangro, Bruno
    Paneda, Astrid
    Grossios, Nadina
    Gil-Farina, Irene
    Benito, Alberto
    Twisk, Jaap
    Paz, Maria
    Ruiz, Juan
    Schmidt, Manfred
    Petry, Harald
    Harper, Pauline
    Enriquez de Salamanca, Rafael
    Fontanellas, Antonio
    Prieto, Jesus
    Gonzalez-Aseguinolaza, Gloria
    JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 776 - 783
  • [42] A transdermal oxymorphone patch delivers therapeutic plasma concentrations of oxymorphone: an open label Phase I clinical trial
    Gavin, P.
    El-Tamimy, M.
    Smith, A.
    Krishnarajah, J.
    JOURNAL OF PAIN, 2014, 15 (04): : S85 - S85
  • [43] Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease
    Zhi-Jian Yang
    You-Rong Zhang
    Bo Chen
    Shu-Lan Zhang
    En-Zhi Jia
    Lian-Sheng Wang
    Tie-Bing Zhu
    Chun-Jian Li
    Hui Wang
    Jun Huang
    Ke-Jiang Cao
    Wen-Zhu Ma
    Bin Wu
    Li-Sheng Wang
    Chu-Tse Wu
    Molecular Biology Reports, 2009, 36 : 1323 - 1329
  • [44] Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease
    Yang, Zhi-Jian
    Zhang, You-Rong
    Chen, Bo
    Zhang, Shu-Lan
    Jia, En-Zhi
    Wang, Lian-Sheng
    Zhu, Tie-Bing
    Li, Chun-Jian
    Wang, Hui
    Huang, Jun
    Cao, Ke-Jiang
    Ma, Wen-Zhu
    Wu, Bin
    Wang, Li-Sheng
    Wu, Chu-Tse
    MOLECULAR BIOLOGY REPORTS, 2009, 36 (06) : 1323 - 1329
  • [45] A Phase III, Multicenter, Collaborative, Open-Label Clinical Trial of Sildenafil in Japanese Patients With Pulmonary Arterial Hypertension
    Satoh, Tohru
    Saji, Tsutomu
    Watanabe, Hiroshi
    Ogawa, Satoshi
    Takehara, Kazuhiko
    Tanabe, Nobuhiro
    Yamada, Norikazu
    Yao, Atsushi
    Miyaji, Katsumasa
    Nakanishi, Norifumi
    Suzuki, Yumiko
    Fujiwara, Tadami
    Kuriyama, Takayuki
    CIRCULATION JOURNAL, 2011, 75 (03) : 677 - 682
  • [46] Pulmonary Artery Denervation for Medication Refractory Pulmonary Hypertension (PARPH Study) ― Study Protocol for a Prospective, Open-Label, Single-Arm Clinical Trial ―
    Asano, Ryotaro
    Nagase, Satoshi
    Aoki, Tatsuo
    Ueda, Jin
    Tsuji, Akihiro
    Asakura, Koko
    Fukuda-Doi, Mayumi
    Inoue, Yuko
    Kusano, Kengo
    Yamamoto, Haruko
    Ogo, Takeshi
    CIRCULATION REPORTS, 2025, 7 (03) : 212 - 215
  • [47] A National Study of Nodal Upstaging After Thoracoscopic Versus Open Lobectomy for Clinical Stage I Lung Cancer
    Licht, Peter B.
    Jorgensen, Ole Dan
    Ladegaard, Lars
    Jakobsen, Erik
    ANNALS OF THORACIC SURGERY, 2013, 96 (03): : 943 - 950
  • [48] Phase-shift tinnitus treatment: an open prospective clinical trial
    Vermeire, K.
    Heyndrickx, K.
    De Ridder, D.
    Van de Heyning, P.
    B-ENT, 2007, : 65 - 69
  • [49] Open-label Phase I/II clinical trial of pyrimethamine for the treatment of chronic GM2 gangliosidosis
    Clarke, Joe
    Kolodny, Edwin
    Mahuran, Don
    Fuller, Maria
    Tropak, Michael
    Keimel, Jack
    Sathe, Swati
    Pesotchinsky, Sophia
    Rigat, Brigette
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S14 - S14
  • [50] Phase I clinical and pharmacologic trial of intravenous estramustine phosphate
    Hudes, G
    Haas, N
    Yeslow, G
    Gillon, T
    Gunnarsson, PO
    Ellman, M
    Nordle, O
    Eriksson, B
    Miller, L
    Cisar, L
    Kopreski, M
    Viaro, D
    Hartley-Asp, B
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) : 1115 - 1127